Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anja-Tatjana Teck"'
Autor:
Anne Letsch, Annika Nelde, Petra Quass, Sabrina Urban, Antonia Busse, Sebastian Ochsenreither, Ulrich Keilholz, Anja Tatjana Teck, Heiko Schuster, Juliane S. Walz
Publikováno v:
Cancer Immunology, Immunotherapy
Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC
Autor:
Anja Tatjana Teck, Sabrina Urban, Petra Quass, Annika Nelde, Heiko Schuster, Anne Letsch, Antonia Busse, Juliane Sarah Walz, Ulrich Keilholz, Sebastian Ochsenreither
Publikováno v:
Cancer Immunology, Immunotherapy
Cyclin A1 is a promising antigen for T cell therapy being selectively expressed in high-grade ovarian cancer (OC) and acute myeloid leukemia (AML) stem cells. For adoptive T cell therapy, a single epitope has to be selected, with high affinity to MHC
Autor:
Ulrich Keilholz, Sebastian Ochsenreither, Sabrina Urban, Anja-Tatjana Teck, Petra Quass, Juliane S. Walz, Annika Nelde
Publikováno v:
Journal of Clinical Oncology. 35:e23080-e23080
e23080 Background: Cyclin A1 is a promising antigen for T-cell therapy being selectively expressed in ovarian cancer and AML stem cells. For adoptive T-cell therapy, a single epitope has to be selected, which should bind with high affinity to MHC cla